JAK2 and cancer: Despite the finding that the suppression of WNT/β‐catenin signaling on account of ectopic PRDM5 expression was determined in limited cancer cell lines,12 we first explored and identified the inhibition of JAK2/STAT3 pathway in LUAD cell lines with PRDM5 overexpression.